ASP Isotopes Inc. is an advanced materials company focused on the separation and enrichment of isotopes for specialized applications across multiple industries. The company operates through two primary segments: Specialist Isotopes and Related Services, and Nuclear Fuels. The Specialist Isotopes segment focuses on producing high-value, low-volume isotopes such as Molybdenum-100 and Ytterbium-176 for radiopharmaceuticals and nuclear medicine, Carbon-14 for pharmaceutical and environmental tracing, and Silicon-28 for advanced semiconductors and quantum computing. The Nuclear Fuels segment, operating primarily through its Quantum Leap Energy subsidiary, is developing technologies to produce High-Assay Low-Enriched Uranium (HALEU) and Lithium-6 for next-generation nuclear reactors. ASP Isotopes utilizes its proprietary Aerodynamic Separation Process (ASP) and laser-based Quantum Enrichment technologies, operating enrichment facilities in Pretoria, South Africa. The company's strategic focus is on addressing global supply chain vulnerabilities by providing a reliable alternative to incumbent, often state-owned, isotope suppliers.
